Logo Made in Germany
presented by Logo BMWi
in cooperation with Logo AUMA
Key-Visual BioJapan 2018

BioJapan 2018

10 – 12 October 2018 – Yokohama, Japan

Meet 20 German companies

Welcome to the German Pavilion at BioJapan 2018!

BioJapan 2018
10 – 12 October 2018
Yokohama, Japan

Welcome to the German Pavilion at BioJapan 2018!

Germany is one of Europe`s most important players in the field of biotechnology.

The number of biopharmaceuticals in clinical development increased from 604 to 627 (+4%) within the year, reflecting the continued high investments in the biopharmaceutical pipeline. The pipeline increased especially strongly in the early phase of clinical development (+11% in phase I).

At BioJapan 2018 in Yokohama 20 German companies and institutions will present themselves with their ambitious product developments and services in the German official presentation at BioJapan annual convention. These companies and institutions are convinced that their products and ideas will be received with great interest.

The German Federal Ministry for Economic Affairs and Energy (BMWi), the AUMA, Association of the German Trade Industry, German Association of Biotechnology Industries of the German Chemical Industry Association (DIB) and the German Biotechnology-Industry-Organization BIO Deutschland welcome you to the official German Presentation at BioJapan 2018 in Yokohama.

Exhibitors at the German Pavilion


Charité Research Organisation GmbH
CRO Offering - Study Example
Booth number: D-35-08

Intana Bioscience GmbH
siPOOL: complex mix of siRNAs agains target gene incl pos. and neg. Control
Booth number: D-35-03

Iris Biotech GmbH
Xylan, Pharma Grade - Key Starting Material for Pentosan Polysulfate
Booth number: D-35-10

Bicoll GmbH
Natural based medicinal chemistry
Booth number: D-35-18

SIRION Biotech GmbH
Booth number: D-35-17

Charité Research Organisation GmbH
CRO Offering - Overview
Booth number: D-35-08

View all German exhibitors and products

News & Innovations

CCDRD AG - Member of The Biosimilars Group
The Biosimilars Group is a network of specialized partners each with its solid core competence in biotechnology provides its clients a pool of expert knowledge and expertise in order to advance the development of biosimilars. CCDRD AG, the clinical development of biosimilar Erythropoetin, resu... | Further reading

SIRION Biotech and Acucela Set Sights on Gene Delivery Tools for Ocular Gene Therapy
MUNICH, GERMANY (January 8, 2018) — SIRION Biotech GmbH (“SIRION”), a world leader in virus based technology innovation and gene delivery expert providing custom services to commercial partners worldwide, announced today that it signed a two year development agreement... | Further reading

Next-generation AAV gene therapy from joined German forces
SIRION Biotech GmbH and Heidelberg University Hospital sign alliance deal for development of novel AAV capsids and technologies addressing shortcomings of clinical gene therapy trials. The viral vector specialist SIRION Biotech GmbH today announces the signing of a preferred partnership agreeme... | Further reading

News & Innovations
Your personal organizer

Your personal organizer

Print list  |  Save as PDF